Wilmington PharmaTech Launches $50 Million Expansion to Double U.S. Small‑Molecule API Manufacturing Capacity in Delaware
On Mar. 23, 2026, Wilmington PharmaTech, a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex…